BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7361617)

  • 1. "Neuraminidase-resistant" sialic acid residues of gangliosides.
    Schauer R; Veh RW; Sander M; Corfield AP; Wiegandt H
    Adv Exp Med Biol; 1980; 125():283-94. PubMed ID: 7361617
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymic degradation of gangliosides.
    Li YT; King MJ; Li SC
    Adv Exp Med Biol; 1980; 125():93-104. PubMed ID: 7361629
    [No Abstract]   [Full Text] [Related]  

  • 3. Horse erythrocyte gangliosides: preparation of the major hematoside NeuNG1-Lac-Cer.
    Maget-Dana R; Michalski JC
    Lipids; 1980 Sep; 15(9):682-5. PubMed ID: 7421423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside.
    Wenger DA; Wardell S
    Physiol Chem Phys; 1972; 4(3):224-30. PubMed ID: 4376840
    [No Abstract]   [Full Text] [Related]  

  • 5. An improved method for the measurement of total lipid-bound sialic acids after cleavage of alpha 2,8 sialic acid linkage with Vibrio cholerae sialidase in the presence of cholic acid, SDS and Ca2+.
    Maliakal MA; Ravindranath MH; Irie RF; Morton DL
    Glycoconj J; 1994 Apr; 11(2):97-104. PubMed ID: 7804012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid release by Vibrio cholerae sialidase (neuraminidase) from the outer surface of neural cells is greatly raised by halothane.
    Knight PR; Nahrwold ML; Rosenberg A
    J Neurochem; 1978 Jun; 30(6):1645-7. PubMed ID: 671010
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of sialic acids.
    Reuter G; Schauer R
    Methods Enzymol; 1994; 230():168-99. PubMed ID: 8139495
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrolysis of all gangliosides, including GM1 and GM2, on thin-layer plates by Vibrio cholerae neuraminidase.
    Portoukalian J; Bouchon B
    J Chromatogr; 1986 Aug; 380(2):386-92. PubMed ID: 3760066
    [No Abstract]   [Full Text] [Related]  

  • 9. VCN-releasable sialic acid and gangliosides in human neuroblastomas.
    Shochat SJ; Abt AB; Schengrund CL
    J Pediatr Surg; 1977 Jun; 12(3):413-8. PubMed ID: 874729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of gangliosides in micellar and liposomal dispersion by bacterial neuraminidases.
    Gatt S; Gazit B; Cestaro B; Barenholz Y
    Adv Exp Med Biol; 1980; 125():137-46. PubMed ID: 6244720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of Vibrio cholerae sialidase action on gangliosidic substrates at different supramolecular-organizational levels.
    Venerando B; Cestaro B; Fiorilli A; Ghidoni R; Preti A; Tettamanti G
    Biochem J; 1982 Jun; 203(3):735-42. PubMed ID: 7115311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the incorporation of N-(acetyl-3 H)mannosamine into the sialic acid of the major retinal gangliosides, studied in vivo.
    Holm M; Månsson JE
    FEBS Lett; 1974 Sep; 46(1):200-2. PubMed ID: 4420170
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of the biological activities of the thermostable direct hemolysin of Vibrio parahaemolyticus by ganglioside Gt1.
    Takeda Y; Takeda T; Honda T; Miwatani T
    Infect Immun; 1976 Jul; 14(1):1-5. PubMed ID: 947841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase gangliosides interactions.
    Tettamanti G; Cestaro B; Venerando B; Preti A
    Adv Exp Med Biol; 1978; 101():417-37. PubMed ID: 665377
    [No Abstract]   [Full Text] [Related]  

  • 15. The ganglioside content of the milk fat-globule membrane and the mouse mammary-tumour virus isolated from the milk of infected mice. Partial characterization of a new disialoganglioside.
    Gosselin-Rey C; Gosselin L; Calberg-Bacq CM; François C; Kozma S; Osterrieth PM; Van Dessel G
    Eur J Biochem; 1980; 107(1):25-30. PubMed ID: 6249587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
    Hinou H; Kurogochi M; Shimizu H; Nishimura S
    Biochemistry; 2005 Sep; 44(35):11669-75. PubMed ID: 16128567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preparation of Tay-Sachs ganglioside specifically labeled in either the N-acetylneuraminosyl or N-acetylgalactosaminyl portion of the molecule.
    Tallman JF; Kolodny EH; Brady RO
    Methods Enzymol; 1975; 35():541-8. PubMed ID: 1121293
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of endogenous substrate with solubilized bovine brain sialidase.
    Schengrund CL; Repman MA
    J Neurosci Res; 1986; 15(2):175-84. PubMed ID: 3959129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and quantitation of gangliosides as p-bromophenacyl derivatives by high-performance liquid chromatography.
    Nakabayashi H; Iwamori M; Nagai Y
    J Biochem; 1984 Oct; 96(4):977-84. PubMed ID: 6520128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of neuraminidase for improving the properties of the erythrocytic ganglioside diagnosticum].
    Dolmatova LA; Goloseev IuA; Narbugovich NI; Efremenko VI; Vladimtseva IV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):35-7. PubMed ID: 4072495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.